Effects of recombinant leptin therapy in a child with congenital leptin deficiency
Article Abstract:
Leptin treatment may be beneficial for obese children. Leptin is a hormone involved in regulating body weight. Researchers treated a 9-year-old girl with leptin deficiency with daily injections of recombinant leptin. At the beginning of therapy, she weighed 207 pounds. During the one-year treatment, she lost about 36 pounds at the rate of 2 to 4 pounds per month. Her fat mass dropped considerably but her lean body mass increased. Her basal metabolic rate also decreased 18%, but she became more physically active. Her body produced antibodies against the injected leptin but the antibodies did not seem to change the effectiveness of the treatment.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene
Article Abstract:
A mutation in the gene for the melanocortin 4 receptor appears to be one cause of obesity, according to a study of 500 obese children. This gene codes for the receptor for an enzyme called alpha melanocyte-stimulating hormone. The hormone causes a decrease in food consumption. The mutation would create a defective receptor, which could interfere with the proper function of the hormone.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Melanocortin receptors weigh in
Article Abstract:
The melanocortin-4 receptor (MC4R) that is highly expressed in the brain acts as a central regulator of food intake and fat mass. The studies confirming the MC4R links to obesity is presented.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The effect of finasteride in men with benign prostatic hyperplasia. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
- Abstracts: Effects of vesnarinone on morbidity and mortality of patients with heart failure. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
- Abstracts: Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States
- Abstracts: Association of two loci on chromosome 2q with nodal osteoarthritis. Radiographic assessment of patellofemoral osteoarthritis
- Abstracts: Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease. Parathyroid hormone-related protein levels in maternal and cord blood